Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3174-2026

Brand Name: VERIQA; Product Name: RT MonteCarlo 3D v3; Recall

Brand Name: VERIQA; Product Name: RT MonteCarlo 3D v3; Model/Catalog Number: S070031.520; Software Version: 3.1.18;

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: VERIQA; Product Name: RT MonteCarlo 3D v3;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3174-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 4, 2026
FDA report date
Sep 23, 2026
Quantity in commerce
2
Distribution
See key details
FDA cause
Software design

What is being recalled?

Brand Name: VERIQA; Product Name: RT MonteCarlo 3D v3; Model/Catalog Number: S070031.520; Software Version: 3.1.18;

Affected model & UDI checker

Search the exact identifiers published for Z-3174-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
S070031.520Brand Name: VERIQA; Product Name: RT MonteCarlo 3D v3;Check source noticeNot specified
FDA code information

Model/Catalog Number: S070031.520; UDI-DI: +EPTWS070031Q5200; Software Version 3.1.18;

View the original FDA recall notice

Why was this product recalled?

When a bolus is included in a treatment plan and sent for secondary dose calculation, the software accounts for it but does not display this clearly, which may lead users to incorrectly omit the bolus during treatment and deliver the prescribed dose to the wrong tissue depth.

What actions did PTW FREIBURG take?

On August 13, 2026 URGENT: MEDICAL DEVICE CORRECTION letters were sent to customers. Actions to be taken: If a user is unsure whether a bolus must be used for treatment or not, VERIQA RT MonteCarlo 3D must not be used as the source of information. The user must rely exclusively on the information from the TPS and from the patient record to determine whether a bolus is used for treatment or not. VERIQA RT MonteCarlo 3D must not have any influence on the treatment workflow or on the treatment plan. This error will be fixed in the next VERIQA RT MonteCarlo 3D release. Please forward this notice to everyone in your organization, or in any other organization using VERIQA RT MonteCarlo 3D version 3.1.18, who needs to be aware of it.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology